Explore

Trendline Trendline
BioLife Solutions Reports 25% Revenue Increase in Q1 2026, Strengthening Market Position

BioLife Solutions Reports 25% Revenue Increase in Q1 2026, Strengthening Market Position

BioLife Solutions Reports 25% Revenue Increase in Q1 2026, Strengthening Market Position
Trendline Trendline
Rocket Pharmaceuticals Reports Financial Results and Progress in Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Progress in Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Progress in Gene Therapy Pipeline
Trendline Trendline
Sarepta Therapeutics Reports Q1 2026 Financial Results Amidst Strategic Developments

Sarepta Therapeutics Reports Q1 2026 Financial Results Amidst Strategic Developments

Sarepta Therapeutics Reports Q1 2026 Financial Results Amidst Strategic Developments
Trendline Trendline
Evommune Reports Q1 2026 Financial Results and Advances Inflammatory Disease Therapies

Evommune Reports Q1 2026 Financial Results and Advances Inflammatory Disease Therapies

Evommune Reports Q1 2026 Financial Results and Advances Inflammatory Disease Therapies
Trendline Trendline
Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline

Zai Lab Reports Q1 2026 Financial Results and Advances Oncology Pipeline
Trendline Trendline
Zura Bio Reports Strong Financial Position and Progress in Clinical Trials

Zura Bio Reports Strong Financial Position and Progress in Clinical Trials

Zura Bio Reports Strong Financial Position and Progress in Clinical Trials
Trendline Trendline
Rocket Pharmaceuticals Reports Financial Results and Advances Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Advances Gene Therapy Pipeline

Rocket Pharmaceuticals Reports Financial Results and Advances Gene Therapy Pipeline
Trendline Trendline
Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate

Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate

Nektar Therapeutics Strengthens Financial Position Amidst Development of Lead Biologic Candidate
Trendline Trendline
Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amidst Growth Initiatives

Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amidst Growth Initiatives

Arrowhead Pharmaceuticals Reports Strong Fiscal 2026 Second Quarter Results Amidst Growth Initiatives
Trendline Trendline
ImmunityBio Reports Significant Revenue Growth in Q1 2026 Driven by ANKTIVA Sales

ImmunityBio Reports Significant Revenue Growth in Q1 2026 Driven by ANKTIVA Sales

ImmunityBio Reports Significant Revenue Growth in Q1 2026 Driven by ANKTIVA Sales
Trendline Trendline
Soligenix Reports Financial Results and Strategic Updates Amid Clinical Trial Challenges

Soligenix Reports Financial Results and Strategic Updates Amid Clinical Trial Challenges

Soligenix Reports Financial Results and Strategic Updates Amid Clinical Trial Challenges
Trendline Trendline
EyePoint Inc. Reports Increased Losses Amid Phase 3 Clinical Trials Funding

EyePoint Inc. Reports Increased Losses Amid Phase 3 Clinical Trials Funding

EyePoint Inc. Reports Increased Losses Amid Phase 3 Clinical Trials Funding